LKC Technologies
English
English Español Português 日本
  • Products
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Sensor Strips
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Applications
    • Visual Electrophysiology
      • Electroretinography (ERG)
      • Visual Evoked Potential (VEP)
    • Clinical Conditions
      • Diabetic Retinopathy
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Animal Applications
  • Resources
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Research
    • Blog
    • Videos
    • Software
  • About LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Testimonials
    • History
  • Contact
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips

Diabetic Retinopathy

Show:

RETeval
Sensor Strips
RETevet
Menu
  • Animal
  • Central Retinal Vein Occlusion
  • Diabetic Retinopathy
  • Flicker ERG
  • Inherited Retinal Diseases
  • Optic Nerve Disorders
  • Pediatric
  • Photopic Negative Response
  • Sensor Strips

Electroretinograms Recorded with Skin Electrodes from Post-Vitrectomy Silicone Oil Filled Eyes with Proliferative Diabetic Retinopathy

July 30, 2024
Kanai K, Igawa Y, Tachibana M, et al. Electroretinograms Recorded with Skin Electrodes from Post-Vitrectomy Silicone Oil Filled Eyes with Proliferative Diabetic Retinopathy. Published online July 30, 2024.

Visual Function Measurements in Eyes with Diabetic Retinopathy: An Expert Opinion on Available Measures

April 6, 2024
Glassman AR, Elmasry MA, Baskin DE, et all. Ophthalmology Science. 2024.

Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems

February 12, 2024
Arias-Alvarez M, Tomas-Grasa C, Sopeña-Pinilla M, et al. Sci Rep. 2024;14(1):3520.

Early diabetic eye damage: Comparing detection methods using diagnostic power

January 30, 2024
Rai BB, Kleef JP van, Sabeti F, Vlieger R, Suominen H, Maddess T. Early diabetic eye damage: Comparing detection methods using diagnostic power. Published online January 2024.

Improved predictive diagnosis of diabetic macular edema based on hybrid models: An observational study

January 11, 2024
Hughes-Cano JA, Quiroz-Mercado H, Hernández-Zimbrón LF, et al. Computers in Biology and Medicine. 2024;170:107979. doi:10.1016/j.compbiomed.2024.107979

What else can we do to prevent diabetic retinopathy?

June 6, 2023
Simó R, Hernández C. What else can we do to prevent diabetic retinopathy. Published online June 6, 2023.

The association between decreased choriocapillary flow and electroretinogram impairments in patients with diabetes

June 1, 2023
Deng X. Photodiagnosis and Photodynamic Therapy. Volume 42, June 2023.
Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes

Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes.

March 31, 2023
Kirthi V, Reed KI, Alattar K, et al. Diabet Med. 2023;40(3):e14952.

Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals

January 12, 2023
Noguez Imm R, Muñoz-Benitez J, Medina D, et al. Barnes S, ed. PLoS ONE. 2023;18(1):e0278388. doi:10.1371/journal.pone.0278388

Are we overlooking the neurodegeneration in the early stage of Type 1 Diabetes Mellitus without Visual Impairment or Diabetic Retinopathy?

November 29, 2022
Jia Y, Lin Q, Xiao Y, Zhou X, Zou H, Yang C. Current Eye Research. Published online November 24, 2022:1-17.

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

August 23, 2021
Simó R, Simó-Servat O, Bogdanov P, Hernández C. Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy. Published online August 23, 2021.

A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models

October 14, 2020
Pearce E, Sivaprasad S. A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models. Clinical Ophthalmology. Published online October 14, 2020.

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

August 4, 2020
Mitchell G. Brigell; Bryce Chiang; April Yauguang Maa; C. Quentin Davis. Translational Vision Science & Technology August 2020, Vol.9, 40.
2006_predictive-value-of-erg-oct-a-and-uwf-fa-in-patients-with-diabetic-retinopathy_abstract

Predictive Value of ERG, OCT-A, and UWF-FA in Patients with Diabetic Retinopathy

June 1, 2020
This abstract assesses the value of electroretinography (ERG), OCT-angiography (OCT-A), and ultra-wide field fluorescein angiography (UWF-FA) parameters to predict progression…
Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device

Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device

November 1, 2019
According to this study published in China, the DR assessment protocol in RETeval device was effective in screening for Diabetic…
Retinal Vasculature-function

Retinal vasculature–function correlation in non-proliferative diabetic retinopathy

October 1, 2019
The purpose of this publication was to compare and correlate retinal microcirculation and function in patients with non-proliferative diabetic retinopathy…
Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy-ok

Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy

January 1, 2019
Zeng Y, Cao D, Yu H, et al. British Journal of Ophthalmology 2019;103:1747-1752.

Neurodegeneration in non‐proliferative diabetic retinopathy: new biomarkers and their relation to vasculopathy and visual function.

December 12, 2018
Nguyen A, Naso S, Mouna A, Kardon R, Kawasaki A. Acta Ophthalmologica. Vol 96. ; 2018:88-89.
Role of a Mydriasis-Free

Role of a Mydriasis-Free, Full-Field Flicker ERG Device in the Detection of Diabetic Retinopathy

October 17, 2018
The purpose of this research is to determine if the RETeval system can be used for the screening of diabetic retinopathy (DR)…
diabetes-and-its-complications

A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy

April 1, 2016
Author(s): Maa, A. Y., W. J. Feuer, C. Q. Davis, E. K. Pillow, T. D. Brown, R. M. Caywood, J…

Current and Next Generation Portable Screening Devices for Diabetic Retinopathy

February 16, 2016
Micheletti JM, Hendrick AM, Khan FN, Ziemer DC, Pasquel FJ. Current and Next Generation Portable Screening Devices for Diabetic Retinopathy. Published online February 16, 2016.
LKC Logo

New Technologies in Diabetic Retinopathy

January 1, 2016
Author(s): Magdalena Gaca-Wysocka, Andrzej Grzybowski Publication: Ophthalmic Care for the Diabetic Patient – selected international experiences., Publisher: Foundation of Ophthalmology Development…
LKC Logo

New Handheld, Non-Mydriatic ERG Device to Screen for Diabetic Retinopathy and Other Eye Diseases

January 1, 2014
Author(s): Kim, Don B, Ross, Evelyn, Pham, Kimberly, Nguyen, Jenny, Nam, Vinna, Gunasekaran, Vidhya, Brodie, Scott E, Wu, Gloria Poster presented…
  • Products
    • RETeval
    • UTAS mf/PERG
    • Sensor Strips
    • RETevet
  • Electrophysiology Tests
    • Electroretinography (ERG)
    • Full-Field ERG (ffERG)
    • Pattern ERG (PERG)
    • Multifocal ERG (mfERG)
    • Visual Evoked Potential (VEP)
    • Address2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • Phone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • International Distributors
      • Medical Device Distributors
      • Veterinary Device Distributors
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity